Alembic Limited (ALEMBICLTD) fundamentals
Alembic Limited is a listed company in Realty, part of the Realty sector, listed on the NSE as ALEMBICLTD (ISIN INE426A01027). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Alembic Limited does
Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.
Valuation and market data
| Last close | ₹105.30 |
|---|---|
| Market capitalisation | ₹1,073 crore |
| Enterprise value | ₹1,115 crore |
| P/E (TTM) | 8.52 |
| Price to book | 0.44 |
| Price to sales (TTM) | 2.18 |
| Book value per share | ₹239.99 |
| Dividend yield | 227.92% |
| Sector | Realty |
| Industry | Realty |
| Listed since | Wed Sep 22 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹305 crore | ₹147 crore | ₹125 crore | 4.85 |
| Mar 2025 | ₹289 crore | ₹152 crore | ₹142 crore | 5.53 |
| Mar 2024 | ₹207 crore | ₹103 crore | ₹93 crore | 3.62 |
| Mar 2023 | ₹187 crore | ₹85 crore | ₹79 crore | 3.09 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 70.9% |
|---|---|
| Foreign institutions (FII) | 1.3% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.1% |
| Retail and others | 27.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.